Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis

被引:50
作者
Gorman, JD
David-Vaudey, E
Pai, M
Lum, RF
Criswell, LA
机构
[1] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[3] Univ Toulouse 3, F-31062 Toulouse, France
[4] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 11期
关键词
D O I
10.1002/art.20588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine the relationship of the HLA-DRB1 shared epitope (SE) to rheumatoid vasculitis, using individual patient data (IPD) meta-analytic methods. Methods. Published studies that enrolled adult patients with rheumatoid arthritis (RA) were identified by searches of Medline and Embase, and by manual searches of medical journals. All authors were contacted for IPD. Meta-analyses were performed to assess the association of SE presence, dose, and genotype with rheumatoid vasculitis. Results. A total of 14 studies and 1,568 patients (129 with vasculitis) were included in the analysis. RA patients with vasculitis were significantly more likely to have rheumatoid nodules (odds ratio [OR] 2.5, 95% confidence interval [95% CI] 1.5-3.9], but there was no significant association with male sex, rheumatoid factor positivity, or erosive disease. No significant association was observed between the presence of the SE (i.e., 1 or 2 alleles versus 0 alleles) and rheumatoid vasculitis (summary OR 1.4, 95% CI 0.7-2.7). Analysis by SE genotype, however, demonstrated a striking relationship of vasculitis to 3 genotypes containing a double dose of the SE, specifically HLA-DRB1*0401/*0401 (OR 6.2, 95% CI 1.01-37.9), *0401/*0404 (OR 4.1, 95% CI 1.1-16.2), and *0101/*0401 (OR 4.0, 95% CI 1.4-11.6). Conclusion. The HLA-DRB1 SE genotypes *0401/ *0401, *0401/*0404, and *0101/*0401 may be of particular importance to rheumatoid vasculitis. It is hoped that additional investigation of these and other SE genotypes will lead to improved insight into the mechanisms influencing the clinical expression of RA.
引用
收藏
页码:3476 / 3484
页数:9
相关论文
共 48 条
  • [1] Amoli MM, 2001, J RHEUMATOL, V28, P1600
  • [2] Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis
    Bas, S
    Perneger, TV
    Mikhnevitch, E
    Seitz, M
    Tiercy, JM
    Roux-Lombard, P
    Guerne, PA
    [J]. RHEUMATOLOGY, 2000, 39 (10) : 1082 - 1088
  • [3] BENAZET JF, 1995, J RHEUMATOL, V22, P607
  • [4] EXAMINATION OF HLA-DR4 AS A SEVERITY MARKER FOR RHEUMATOID-ARTHRITIS IN GREEK PATIENTS
    BOKI, KA
    DROSOS, AA
    TZIOUFAS, AG
    LANCHBURY, JS
    PANAYI, GS
    MOUTSOPOULOS, HM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (07) : 517 - 519
  • [5] Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
  • [6] BROWNING M, 1996, HLA CLASS II GENES S
  • [7] *COLL STAT STAT CO, 2003, STAT STAT SOFTW REL
  • [8] Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis
    Cortet, B
    Perez, T
    Roux, N
    Flipo, RM
    Duquesnoy, B
    Delcambre, B
    RemyJardin, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (10) : 596 - 600
  • [9] Criswell LA, 1998, GENET EPIDEMIOL, V15, P61
  • [10] Bias in meta-analysis detected by a simple, graphical test
    Egger, M
    Smith, GD
    Schneider, M
    Minder, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109): : 629 - 634